Clene Inc. Long-term Debt, Gross
Clene Inc. (CLNN) had Long-term Debt, Gross of $18.72 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:DebtInstrumentCarryingAmount · last filed 2026-08-14
- 2026-06-30: Long-term Debt, Gross $18.72M.
- 2026-03-31: Long-term Debt, Gross $18.20M.
- 2025-12-31: Long-term Debt, Gross $17.61M.
- 2025-09-30: Long-term Debt, Gross $17.05M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2026-06-30 | $18.72M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $18.20M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $17.61M 10-K · filed 2026-03-17 |
| 2025-09-30 | $17.05M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $16.13M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $16.03M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $5.50M 10-K · filed 2025-03-24 |
| 2024-09-30 | $11.95M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $21.94M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $16.93M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $16.91M 10-K · filed 2025-03-24 |
| 2022-12-31 | $16.49M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |